Trials / Recruiting
RecruitingNCT07162441
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Korea United Pharm. Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study is open-label, multiple-dose, two-intervention group, single-sequence, crossover design to compare the safety and pharmacokinetics of UIC202502 and UIC202505 when administered alone or in combination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | treatment A | UIC202502 1 Tab/day for 7 days |
| DRUG | treatment B | UIC202505 1 Tab/day for 7 days |
| DRUG | treatment C | UIC202502+UIC202505 2 Tab/day for 7 days |
Timeline
- Start date
- 2025-08-12
- Primary completion
- 2025-09-30
- Completion
- 2026-03-01
- First posted
- 2025-09-09
- Last updated
- 2025-09-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07162441. Inclusion in this directory is not an endorsement.